Volume 120, Issue 4, Pages (March 2001)

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

Celiac disease–like abnormalities in a subgroup of patients with irritable bowel syndrome Ulrich Wahnschaffe, R. Ullrich, E.O. Riecken, J.D. Schulzke Gastroenterology.
Serum immunoglobulin a from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation Tuula Halttunen, Markku Mäki.
Interleukin 15 mediates epithelial changes in celiac disease Luigi Maiuri, Carolina Ciacci, Salvatore Auricchio, Virginia Brown, Sonia Quaratino, Marco.
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease Richard N. Fedorak, *, Alfred Gangl, ‡, Charles.
Volume 120, Issue 4, Pages (March 2001)
Gemcitabine plus cisplatin versus chemoradiotherapy in locally advanced biliary tract cancer: Fédération Francophone de Cancérologie Digestive 9902 phase.
Volume 90, Issue 5, Pages (November 1986)
Volume 44, Issue 1, Pages (February 2017)
Volume 140, Issue 5, Pages (November 2011)
It's time to bring the best and brightest back to gastroenterology!
Volume 117, Issue 4, Pages (October 1999)
AGA technical review on irritable bowel syndrome
Volume 122, Issue 1, Pages (January 2002)
Volume 122, Issue 4, Pages (April 2002)
An enormous ventral (epigastric) hernia as a cause of acute pancreatitis: Pfeffer's closed duodenal loop model in the animal, first seen in a human  Paul.
Oral Diosmectite Reduces Stool Output and Diarrhea Duration in Children With Acute Watery Diarrhea  Christophe Dupont, Jimmy Lee Kok Foo, Philippe Garnier,
Volume 122, Issue 3, Pages (March 2002)
Diagnosis of irritable bowel syndrome
Volume 2, Issue 6, Pages (November 2016)
Volume 122, Issue 1, Pages (January 2002)
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?  William E. Whitehead, Olafur.
Pancreatic enzyme replacement therapy for young cystic fibrosis patients  Anne Munck, Jean-Francois Duhamel, Thierry Lamireau, Bernard Le Luyer, Claire.
Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: A multicenter prospective randomized study  Jean-Pierre.
Chromoendoscopic Colonoscopy for Detecting Preneoplastic Lesions in Hereditary Nonpolyposis Colorectal Cancer Syndrome  Thierry Lecomte, Christophe Cellier,
Polyxeni Koutkia, Zhiren Lu, Tai C. Chen, Michael F. Holick 
Volume 120, Issue 2, Pages (February 2001)
Volume 124, Issue 4, Pages (April 2003)
Volume 120, Issue 6, Pages (May 2001)
Liver fibrosis in overweight patients
Hepatitis B infection in heart transplant recipients
Clinical Image Quality and Sensitivity in an Organized Mammography Screening Program  Isabelle Théberge, PhD, Marie-Hélène Guertin, MSc, PhD, Nathalie.
Appendectomy is followed by increased risk of Crohn's disease
Volume 117, Issue 4, Pages (October 1999)
Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C  Chi–Jen Chu, Munira Hussain,
Volume 115, Issue 1, Pages (July 1998)
Volume 116, Issue 1, Pages (January 1999)
Volume 120, Issue 3, Pages (February 2001)
Acute pancreatitis attributed to the use of interferon alfa-2b
Volume 123, Issue 1, Pages (July 2002)
Antje Timmer*, Lloyd R. Sutherland*,‡, Francois Martin§ 
Volume 116, Issue 1, Pages (January 1999)
Jean-Michel Pawlotsky  Gastroenterology 
Volume 124, Issue 4, Pages (April 2003)
Volume 120, Issue 4, Pages (March 2001)
Volume 145, Issue 4, Pages e8 (October 2013)
Severe Constipation Clinical Gastroenterology and Hepatology
Volume 124, Issue 4, Pages (April 2003)
Volume 121, Issue 3, Pages (September 2001)
Volume 122, Issue 7, Pages (June 2002)
Lise L. Kjaergard, Sarah L. Frederiksen, Christian Gluud 
AGA technical review on nonalcoholic fatty liver disease
Complications of screening flexible sigmoidoscopy
Volume 124, Issue 4, Pages (April 2003)
Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease  Francesco S. Facchini, Nancy.
Image of the month Gastroenterology
Volume 122, Issue 3, Pages (March 2002)
Chronic Diarrhea Clinical Gastroenterology and Hepatology
Acute and chronic dissections of the abdominal aorta: Clinical features and treatment  Jean-Pierre Becquemin, MD, Philippe Deleuze, MD, Jacques Watelet,
Intraluminal Duodenal Diverticulum
AGA technical review on osteoporosis in gastrointestinal diseases
Volume 122, Issue 7, Pages (June 2002)
Volume 122, Issue 1, Pages (January 2002)
Volume 128, Issue 7, Pages (June 2005)
Michelle Maria Pietzak  Gastroenterology 
Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down  Eric D. Bateman, MD, Loretta Jacques, PhD,
Hepatic deficiency of interleukin 10 in chronic hepatitis C
Volume 124, Issue 3, Pages (March 2003)
Volume 4, Issue 3, Pages (March 2018)
Volume 120, Issue 4, Pages (March 2001)
Presentation transcript:

Volume 120, Issue 4, Pages 799-805 (March 2001) Efficacy and tolerability of racecadotril in acute diarrhea in children  Jean Pierre Cézard, Jean François Duhamel, Martine Meyer, Isabelle Pharaon, Marc Bellaiche, Chantal Maurage, Jean Louis Ginies, Jean Michel Vaillant, Jean Philippe Girardet, Thierry Lamireau, Alain Poujol, Alain Morali, Jacques Sarles, Jean Pierre Olives, Caroline Whately–Smith, Jeanne Marie Lecomte  Gastroenterology  Volume 120, Issue 4, Pages 799-805 (March 2001) DOI: 10.1053/gast.2001.22544 Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 1 Mean (±SEM) stool output during the first 48 hours of treatment for the full data set and the per-protocol population (covariance analysis). **P = 0.009; ***P = 0.001. Gastroenterology 2001 120, 799-805DOI: (10.1053/gast.2001.22544) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 2 Mean (±SEM) stool output during the first 48 hours of treatment for rotavirus-positive and rotavirus-negative patients (per-protocol population). Treatment effect P = 0.001. Interaction rotavirus × treatment, P = 0.500. Gastroenterology 2001 120, 799-805DOI: (10.1053/gast.2001.22544) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 3 Mean (±SEM) stool output during the first 24 hours of treatment for the full data set and the per-protocol population. *P = 0.025. **P = 0.015. Gastroenterology 2001 120, 799-805DOI: (10.1053/gast.2001.22544) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 4 Time to recovery in rotavirus-positive patients receiving racecadotril (n = 32) and placebo (n = 35). P = 0.02. Gastroenterology 2001 120, 799-805DOI: (10.1053/gast.2001.22544) Copyright © 2001 American Gastroenterological Association Terms and Conditions